Dr. Revati Shreeniwas

Biopharma company developing next-generation mental health treatments Bright Minds Biosciences Inc. (NASDAQ: DRUG) has closed its overnight offering for gross proceeds of approximately $4 million. The company also announced it will start dosing patients in the trial of...